You are viewing: Canada Pharmaceutical Manufacturing Equipment Market analysis

The Canada Pharmaceutical Manufacturing Equipment Market was valued at $733.6 Million in 2026 and projected to reach to $941.1 Million by 2031, representing a compound annual growth rate of 4.2%. Canada's pharmaceutical manufacturing equipment market is poised for sustained growth through 2031, driven by strategic government initiatives to strengthen domestic production capacity and reduce supply chain vulnerabilities.

Canada Pharmaceutical Manufacturing Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Pharmaceutical Manufacturing Equipment Market Trends and Insights

  • This steady expansion reflects Canada's strengthening position as a life sciences hub and increasing investments in domestic pharmaceutical production capacity.
  • Canada's market growth is driven by regulatory modernization, rising demand for advanced manufacturing technologies, and government initiatives supporting pharmaceutical self-sufficiency. The Canadian pharmaceutical manufacturing equipment sector benefits from the country's robust regulatory framework, skilled workforce, and proximity to North American markets.
  • Canada's expansion through 2031 is supported by capital investments in facility upgrades, automation technologies, and quality assurance systems.
  • The market reflects Canada's commitment to enhancing manufacturing capabilities and reducing supply chain vulnerabilities in the pharmaceutical sector..

Key Market Statistics

  • CAGR (2026-2031) 4.2% CAGR
  • Market Size, 2026 ~USD 733.6 Million
  • Forecast, 2031 ~USD 941.1 Million
  • Country Canada

Canada Pharmaceutical Manufacturing Equipment Market Overview

Market Valuation Growth :

Canada's pharmaceutical manufacturing equipment market is valued at $733.6 million in 2026 and is projected to reach $941.1 million by 2031, demonstrating consistent market expansion and investment confidence in domestic production capabilities.

Steady CAGR Performance :

The Canadian market is growing at a 4.2% CAGR from 2026-2031, outpacing global growth expectations and reflecting strong domestic demand for advanced manufacturing technologies in the life sciences sector.

Life Sciences Hub Development :

Canada is strengthening its position as a North American life sciences hub, with increasing government support and private sector investments driving modernization of pharmaceutical manufacturing infrastructure across provinces.

Regulatory-Driven Expansion :

Stringent Canadian regulatory requirements and quality standards are spurring investments in advanced manufacturing equipment, positioning domestic manufacturers to meet both domestic and export market demands.

Canada Pharmaceutical Manufacturing Equipment Market Dynamics

  • The country's commitment to becoming a self-sufficient life sciences leader is attracting significant capital investments in state-of-the-art manufacturing facilities across Ontario, Quebec, and British Columbia. The market will benefit from increasing biopharmaceutical production, vaccine manufacturing expansion, and modernization of existing facilities to meet evolving regulatory standards.
  • With a 4.2% CAGR, Canada's market growth reflects both domestic demand and opportunities to serve North American markets, positioning the country as a competitive alternative to traditional manufacturing hubs..

Related Ecosystem

Industrial Automation

Top Technologies
  • Sensors
  • Image Sensors
  • Manufacturing Execution System (MES)
  • Actuators
  • Flow Sensors
Top Companies
  • Siemens ag
  • ABB India Limited
  • Emerson Electric Co.
  • HONEYWELL INTERNATIONAL INC.
  • SCHNEIDER ELECTRIC SE

    Key Takeaways

    • Canada's pharmaceutical manufacturing equipment market is valued at $733.6 million in 2026 and will reach $941.1 million by 2031 at a 4.2% CAGR.
    • Canada's market growth is supported by government initiatives promoting domestic pharmaceutical production and supply chain resilience.
    • Canada's regulatory environment and skilled workforce position the country as an attractive destination for pharmaceutical manufacturing investments.
    • Canada's market expansion is driven by automation, quality assurance upgrades, and facility modernization across the pharmaceutical sector.

    Pharmaceutical Manufacturing Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment PACKAGING MACHINES (Equipment Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.2% from 2026 to 2031
    Largest Segment AUTOMATIC (Technology)
    Market Size Base Year (Billions) ~USD 21.18 (2026)
    Revenue Forecast (Billions) ~USD 28.62 (2031)
    Segments Covered Equipment Type, End-Product Type, Technology

    Canada Pharmaceutical Manufacturing Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Equipment Type

    • Extrusion Equipment
    • Filling Machines
    • Granulation Equipment
    • Inspection Equipment
    • Milling Equipment
    • Mixing & Blending Machines
    • Packaging Machines
    • Spray Drying Equipment
    • Sterilization Equipment
    • Tablet Compression Presses

    By End-Product Type

    • Liquid
    • Solid

    By Technology

    • Automatic
    • Semi-Automatic

    Target Audience

    • Equipment Manufacturers & Suppliers : Manufacturers of pharmaceutical production equipment need Canada-specific market data to identify growth opportunities, assess competitive positioning, and develop targeted sales strategies for this expanding life sciences market.
    • Pharmaceutical & Biotech Companies : Canadian and international pharma companies planning facility expansions or modernization require detailed market insights to benchmark equipment investments, evaluate supplier options, and optimize capital allocation.
    • Private Equity & Investment Firms : Investors evaluating opportunities in Canada's life sciences sector need market-specific data to assess growth potential, identify acquisition targets, and understand the competitive dynamics of pharmaceutical manufacturing.
    • Government & Policy Makers : Canadian federal and provincial government agencies developing life sciences strategies require market intelligence to inform policy decisions, funding allocations, and initiatives supporting domestic pharmaceutical manufacturing capacity.
    • Consulting & Strategy Firms : Business consultants advising clients on Canadian market entry, expansion, or competitive positioning need authoritative market data to support strategic recommendations and client presentations.

    Key Companies in the Canada Pharmaceutical Manufacturing Equipment Market

    CompanyHQOwnershipStrongest segments
    GEA GROUP AKTIENGESELLSCHAFTUnited StatesPublic CompanySeparation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies,
    KöRBER AGGermanyPrivate CompanySupply chain software, automation, voice, robotics, and material handling,Pharma machinery, equipment, and related software,Technologies: measuring instruments, flavors, food and beverage, and e-mobility equipment,
    IMA INDUSTRIA MACCHINE AUTOMATICHE SPAItalyPrivate CompanyPharmaceutical processing and packaging systems,Food, dairy, and beverage packaging lines,Tea, coffee, and related portioning systems,
    ACGBermudaPublic CompanyInsurance,Reinsurance,Mortgage,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    ELIZABETH COMPANIESUnited StatesPrivate CompanyPrestige and heritage fragrances,Licensed designer and celebrity fragrances,Skincare (Elizabeth Arden, Ceramide, Prevage, Eight Hour, Pro),
    FREUNDJapanPrivate CompanyPharmaceutical granulation and coating equipment,Plant engineering and integrated systems,Pharmaceutical excipients,

    GEA GROUP AKTIENGESELLSCHAFT

    GEA GROUP AKTIENGESELLSCHAFT is a publicly traded company founded in 1881 with 19,670 employees operating in the United States.

    KöRBER AG

    KÖRBER AG is a German private company founded in 1946 with 10,665 employees.

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA

    IMA INDUSTRIA MACCHINE AUTOMATICHE SPA is an Italian private company founded in 1961 with 6,121 employees.

    ACG

    ACG is a publicly traded company based in Bermuda founded in 1995 with 8,000 employees.

    THERMO FISHER SCIENTIFIC INC.

    THERMO FISHER SCIENTIFIC INC. is a publicly traded United States company founded in 1956 with 125,000 employees.

    ELIZABETH COMPANIES

    ELIZABETH COMPANIES is a United States-based private company founded in 1910 with 2,150 employees.

    FREUND

    FREUND is a Japan-based private company founded in 1964 with 427 employees.

    Reasons to Buy this Report

    • Market-Specific Growth Projections : Access detailed forecasts showing Canada's market expanding from $733.6M to $941.1M by 2031, enabling accurate business planning and investment decisions tailored to the Canadian pharmaceutical sector.
    • Competitive Landscape Intelligence : Understand Canada's unique position within North America's pharmaceutical manufacturing ecosystem and identify opportunities to capture market share in this emerging life sciences hub.
    • Regulatory & Compliance Insights : Gain insights into Canadian regulatory drivers and quality standards that are shaping equipment demand, helping suppliers align products with domestic market requirements and export opportunities.
    • Provincial Investment Opportunities : Identify high-growth regions and provincial initiatives across Ontario, Quebec, and British Columbia where pharmaceutical manufacturing investments are concentrated and equipment demand is strongest.
    • Strategic Market Entry Planning : Develop informed go-to-market strategies for Canada with data on market dynamics, growth drivers, and competitive positioning specific to this 4.2% CAGR growth market.

    Frequently asked questions

    What is the current size of Canada's pharmaceutical manufacturing equipment market?

    Canada's pharmaceutical manufacturing equipment market is valued at $733.6 million in 2026.

    What is the projected market size for Canada by 2031?

    Canada's pharmaceutical manufacturing equipment market is projected to reach $941.1 million by 2031.

    What is the growth rate for Canada's pharmaceutical manufacturing equipment market?

    Canada's pharmaceutical manufacturing equipment market is expected to grow at a compound annual growth rate of 4.2% from 2026 to 2031.

    What factors are driving growth in Canada's pharmaceutical manufacturing equipment market?

    Canada's market growth is driven by government initiatives supporting pharmaceutical self-sufficiency, regulatory modernization, automation adoption, and facility upgrades to enhance manufacturing capabilities.

    Why is Canada an attractive market for pharmaceutical manufacturing equipment?

    Canada offers a robust regulatory framework, skilled workforce, proximity to North American markets, and government support for domestic pharmaceutical production, making it an attractive destination for manufacturing investments.

    RESEARCH METHODOLOGY

    The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

    Secondary Research

    Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

    Primary Research

    Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
    Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

    Pharmaceutical Manufacturing Equipment Market Size, and Share

    Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
    Other designations include sales, marketing, and product managers.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

    All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

    Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

    Market Definition

    The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

    The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

    Key Stakeholders

    • Pharmaceutical manufacturing equipment manufacturers
    • End users
    • Automation consultants
    • Research organizations
    • Technology investors
    • Technology standards organizations, forums, alliances, and associations
    • Process automation and instrumentation solution and product suppliers
    • Instrumentation and automation products’ original equipment manufacturers (OEMs)
    • Energy industry associations

    Report Objectives

    • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
    • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
    • To estimate the market size, by equipment type, in terms of volume
    • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
    • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
    • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
    • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
    • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
    • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
    • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
    • To provide a macroeconomic outlook for all regions covered in this report
    • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

     

    Get the Full Pharmaceutical Manufacturing Equipment Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Manufacturing Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status